← All organizations

Revive Therapeutics, Ltd.

For profitWebsite ↗

Also known as: Revive Therapeutics, Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2022

Timeline

2010s

Jun 1, 2012
Revive Therapeutics, Ltd.— Founded

Drugs by trial phase (3 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

bucillamine

Phase 2 (1 own, 0 via acquisition)

colchicine

Phase 1 (1 own, 0 via acquisition)

psilocybin

Indications

Studied for

Recent trials (4)

NCT05322954CollaboratorPhase 1Dec 31, 2022
NCT04504734Lead sponsorPhase 3Nov 27, 2020
NCT02942420Lead sponsorPhase 2May 1, 2017
NCT02330796Lead sponsorPhase 2Apr 1, 2015

Details

Founded: Vaughan, ON, CA Jun 1, 2012
Last known activity: Dec 31, 2022